Corcept Therapeutics Incorporated
CORT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $19,359 | $35,149 | $20,547 | $30,389 |
| Dep. & Amort. | $477 | $469 | $462 | $460 |
| Deferred Tax | $9,114 | -$17,764 | -$13,705 | -$3,858 |
| Stock-Based Comp. | $0 | $19,023 | $21,830 | $16,796 |
| Change in WC | $3,348 | $8,374 | -$22,313 | $17,347 |
| Other Non-Cash | $22,183 | -$1,312 | -$1,693 | -$1,834 |
| Operating Cash Flow | $54,481 | $43,939 | $5,128 | $59,300 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$57 | -$104 | -$121 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$37,355 | -$23,274 | -$115,145 | -$144,572 |
| Inv. Sales/Matur. | $52,000 | $93,458 | $112,078 | $80,333 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $14,645 | $70,127 | -$3,171 | -$64,360 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,203 | $12,510 | $0 | $0 |
| Stock Repurch. | -$42,464 | -$103,018 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$8,152 | -$12,426 | -$39,803 | -$4,564 |
| Financing Cash Flow | -$46,413 | -$102,934 | -$39,803 | -$4,564 |
| Forex Effect | -$320 | $1,794 | $0 | $0 |
| Net Chg. in Cash | $22,393 | $12,926 | -$37,846 | -$9,624 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $102,745 | $89,819 | $127,665 | $137,289 |
| End Cash | $125,138 | $102,745 | $89,819 | $127,665 |
| Free Cash Flow | $54,481 | $43,882 | $5,024 | $59,179 |